EMPOVIR (Emcure Pharmaceuticals Pty Ltd)
Product name
EMPOVIR
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
171 working days (255)
Active ingredients
cidofovir
Registration type
New generic medicine
Indication
EMPOVIR (concentrated injection) is indicated in adults for the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS).